Articles by: Matthew Menke

SteadyMed Gets Notice of Allowance in Europe for Patent Application Relating to Enhanced Reduction of Infusion-Site Pain

SteadyMed Gets Notice of Allowance in Europe for Patent Application Relating to Enhanced Reduction of Infusion-Site Pain

October 16, 2017 at 7:02 pm 0 comments

SteadyMed (STDY), a specialty pharmaceutical company, said Thursday it has received a notice of allowance from the European Patent Office for a patent application related to enhanced infusion-site pain reduction for drug delivery devices. “Currently, infusion-site pain is a common patient complaint when certain therapeutic drugs are delivered subcutaneously,” said CEO Jonathan Rigby. “The patent application relates to the deliveryRead More

Kadmon Shares Jump 13% Pre-Bell as FDA Grants Orphan Designation For Graft-vs-Host Disease Treatmen

Kadmon Shares Jump 13% Pre-Bell as FDA Grants Orphan Designation For Graft-vs-Host Disease Treatmen

October 11, 2017 at 12:37 am 0 comments

Kadmon Holdings (KDMN) shares advanced 13% pre-market trade after the company said the U.S. Food and Drug Administration has granted orphan drug designation to its KD025 for the treatment of chronic graft-versus-host disease (cGVHD), a serious complication following allogeneic bone marrow or stem cell transplantation. KD025 is being studied in an ongoing phase 2 clinical trial in adults with steroid-dependentRead More

Canada Employment Preview: Employment Expected to Rise 20,000 in September

Canada Employment Preview: Employment Expected to Rise 20,000 in September

October 11, 2017 at 12:35 am 0 comments

Employment is expected to rise 20,000 in September after the 22,200 gain in August. Action Economics said it expects annual average weekly earnings growth to expand at a 1.8% year-on-year pace in September, matching the pace in August but up from the 1.3% growth rates in May, June and July. While that would again be above the multi-year low 0.7%Read More

Tupperware Brands Reports Mixed Fiscal Q2

Tupperware Brands Reports Mixed Fiscal Q2

July 26, 2017 at 4:55 pm 0 comments

Tupperware Brands reported fiscal Q2 sales rose 1% to $572.9 million from the year-ago period but missed the CapIQ mean for $580.19 million. Adjusted earnings in the quarter ended July 1 rose 4% to $1.21 from last year and beat forecasts for $1.20. The company said it has decided to wind-down Beauticontrol’s operations over approximately the next 60 to 90Read More

Asian ADRs Slip Lower

Asian ADRs Slip Lower

July 7, 2017 at 3:14 pm 0 comments

American depository receipts of Asian stocks were trading 0.13% lower at 158.89 on the Bank of New York Mellon Asia ADR Index on Friday. In North Asia, the gainers were led by biopharmaceutical company Beigene (BGNE), and aluminum producer Aluminum Corporation of China (ACH), which rose 4.3% and 3.3% respectively. They were followed by Baozun (BZUN), a brand e-commerce solutionsRead More